Randomized phase I trial of adjuvant personalized cancer vaccine TG4050 in resected locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)patients (pts)

C. Le Tourneau, et al.
ASCO 2025
Abstract available on the ASCO website – Download the abstract – Download the Rapid Oral Presentation